Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03899753 · ClinicalTrials.gov registry record · NA
Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond
A NA study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03899753 is a NA study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT03899753, a NA study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The objective is to compare two types of wound closure after total shoulder arthroplasty to determine which closure is faster, and subsequently if there are different outcomes between the two types of closures. The objective of this study is to compare two types of wound closure after total shoulder arthroplasty procedures. A single fellowship trained shoulder surgeon will perform all procedures. It is hypothesized that participants who undergo an 2-Octyl Cyanoacrylate (OCA) mesh closure will have a faster closure time, lower cost, non-inferior complication rate, and non-inferior satisfaction scores with respect postoperative follow up and scar appearance. Participants in the OCA mesh cohort will be compared to participants who have a closure with a running monocryl suture and dermabond. This investigation seeks to determine if OCA closure mesh closure is non-inferior to monocryl suture and dermabond in terms of operative time, cost, complications, and aesthetic appearance. If the hypothesis is confirmed, this study will suggest that a OCA mesh closure may be used for total shoulder arthroplasty surgeries as an alternative to current conventional closures and may provide a cost benefit.
Interventions
- DEVICE 2-Octyl Cyanoacrylate and Mesh
- DEVICE 2-Octyl Cyanoacrylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-12-31 |
| Est. Completion | 2021-04-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03899753
The ClinicalTrials.gov registry entry for NCT03899753 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 2-Octyl Cyanoacrylate and Mesh is the first listed.
NCT03899753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03899753 about?
NCT03899753 is a clinical study titled "Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond". The objective is to compare two types of wound closure after total shoulder arthroplasty to determine which closure is faster, and subsequently if there are different outcomes between the two types of closures. The objective of this study is to compare two types of wound closure after total shoulde...
What is the current status of trial NCT03899753?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2020-12-31. Estimated completion is 2021-04-21.
What interventions are being tested in trial NCT03899753?
The interventions under investigation include: 2-Octyl Cyanoacrylate and Mesh (DEVICE), 2-Octyl Cyanoacrylate (DEVICE).
Who is sponsoring clinical trial NCT03899753?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.